Form 4: Anixa Biosciences Director Lewis H. Titterton Jr. Increases Stake with Recent Stock Purchase

Lewis H. Titterton Jr., a director at Anixa Biosciences, recently purchased 4,000 shares of common stock, increasing his total holdings to 860,612 shares.

Summary

• On June 14, 2024, Lewis H. Titterton Jr., a director of Anixa Biosciences Inc., acquired 4,000 shares of the company's common stock.
• The purchase was made at a price of $2.68 per share.
• Following this transaction, Titterton's total beneficial ownership in Anixa Biosciences amounts to 860,612 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but the transaction is relatively small and doesn't provide a strong signal.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into a company's prospects from those with intimate knowledge of the business.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates